PUNZI, LEONARDO
 Distribuzione geografica
Continente #
NA - Nord America 41.851
AS - Asia 22.734
EU - Europa 9.906
AF - Africa 3.411
SA - Sud America 3.351
OC - Oceania 341
Continente sconosciuto - Info sul continente non disponibili 169
Totale 81.763
Nazione #
US - Stati Uniti d'America 40.018
SG - Singapore 7.528
CN - Cina 4.350
VN - Vietnam 3.244
HK - Hong Kong 2.218
BR - Brasile 1.986
IT - Italia 1.562
DE - Germania 1.160
FR - Francia 905
FI - Finlandia 864
IN - India 658
SE - Svezia 605
PL - Polonia 572
GB - Regno Unito 546
BD - Bangladesh 508
UA - Ucraina 429
RU - Federazione Russa 393
IQ - Iraq 351
NL - Olanda 288
TR - Turchia 285
AR - Argentina 278
JP - Giappone 237
PH - Filippine 228
CA - Canada 220
PK - Pakistan 217
MX - Messico 205
SA - Arabia Saudita 200
ZA - Sudafrica 189
ID - Indonesia 181
UZ - Uzbekistan 175
EC - Ecuador 173
CO - Colombia 155
IE - Irlanda 155
VE - Venezuela 155
ES - Italia 144
JO - Giordania 133
KR - Corea 133
AT - Austria 131
MA - Marocco 128
EG - Egitto 127
MY - Malesia 127
DZ - Algeria 125
ET - Etiopia 118
JM - Giamaica 116
TH - Thailandia 116
KE - Kenya 115
IL - Israele 113
TN - Tunisia 112
NP - Nepal 111
AO - Angola 110
PS - Palestinian Territory 110
AE - Emirati Arabi Uniti 109
PE - Perù 109
BO - Bolivia 108
RO - Romania 108
UY - Uruguay 108
CL - Cile 107
AZ - Azerbaigian 106
AL - Albania 104
PY - Paraguay 104
LB - Libano 103
NI - Nicaragua 102
TT - Trinidad e Tobago 99
GH - Ghana 98
RS - Serbia 98
CZ - Repubblica Ceca 97
TJ - Tagikistan 96
GR - Grecia 95
KG - Kirghizistan 95
AU - Australia 93
BA - Bosnia-Erzegovina 91
BE - Belgio 91
HU - Ungheria 91
HN - Honduras 90
LV - Lettonia 90
DO - Repubblica Dominicana 89
KH - Cambogia 89
MD - Moldavia 89
SN - Senegal 89
PA - Panama 88
BJ - Benin 87
CH - Svizzera 87
PT - Portogallo 87
CR - Costa Rica 86
DK - Danimarca 86
KZ - Kazakistan 86
IR - Iran 85
CY - Cipro 84
NO - Norvegia 84
CM - Camerun 83
YT - Mayotte 83
AM - Armenia 82
BF - Burkina Faso 82
BW - Botswana 82
CV - Capo Verde 82
IS - Islanda 82
TW - Taiwan 82
GE - Georgia 81
PR - Porto Rico 81
SK - Slovacchia (Repubblica Slovacca) 81
Totale 77.816
Città #
Fairfield 5.019
Singapore 4.657
Ashburn 4.509
San Jose 3.524
Woodbridge 3.002
Chandler 2.536
Houston 2.492
Ann Arbor 2.365
Hong Kong 2.031
Seattle 1.734
Wilmington 1.613
Cambridge 1.596
Jacksonville 1.164
Ho Chi Minh City 923
Hanoi 775
Beijing 766
Boardman 707
Princeton 620
Santa Clara 571
Los Angeles 524
San Diego 450
Lauterbourg 424
Des Moines 392
Bytom 383
Medford 383
New York 380
Helsinki 354
Nanjing 305
Guangzhou 259
Roxbury 213
São Paulo 178
Padova 173
Da Nang 159
Chicago 155
Munich 149
Baghdad 145
Dong Ket 145
Tashkent 144
Haiphong 134
Tokyo 130
Dublin 128
Amman 122
Buffalo 121
Hefei 120
Shanghai 118
Milan 113
Orem 112
Dallas 103
Nanchang 102
Hebei 101
London 101
Managua 100
Rome 98
Shenyang 98
Nairobi 97
Baku 95
Addis Ababa 93
Luanda 90
Accra 89
Warsaw 89
Vienna 88
Dakar 87
Dushanbe 87
Phnom Penh 86
Council Bluffs 83
Cotonou 82
Montevideo 82
Riga 82
Bishkek 81
Panama City 81
Redwood City 81
Brooklyn 79
Frankfurt am Main 78
Kingston 77
Chennai 76
Jinan 76
Lusaka 75
Kampala 74
Lahore 73
Lima 73
Praia 73
Ulan Bator 73
Abidjan 72
Changsha 72
San José 71
Tianjin 71
Antananarivo 70
Castries 70
Conakry 70
Jeddah 70
Harare 68
Vientiane 67
Yerevan 67
Kuala Lumpur 66
Montreal 66
Reykjavik 66
Johannesburg 65
Tirana 65
Willemstad 65
Bridgetown 64
Totale 51.245
Nome #
Trattamento riabilitativo in pazienti con spondilite anchilosante trattati con farmaco biologico: studio randonizzato controllato. 523
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints 372
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 347
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. 316
Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus. 309
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 304
Impact of hypertension on vascular remodeling in patients with psoriatic arthritis 302
2016 updated EULAR evidence-based recommendations for the management of gout 301
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. 296
17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. 295
PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis. 291
Fully integrated 18f-fdg pet/mr in large vessel vasculitis 289
Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study. 289
Synovial biomarkers in psoriatic arthritis. 287
Inefficacy or paradoxical effect? Uveitis in ankylosing spondylitis treated with etanercept. 287
AB0953 A Comparison of Region-Based and Pixel-Based CEUS Kinetics Parameters in the Differentiation of Rheumatoid Arthritis and Simil-Rheumatoid Psoriatic Arthritis 285
Anti-inflammatory effects of polyphenols in arthritis 284
Impact of hypertension on vascular remodeling in patients with psoriatic arthritis 284
Advances in the Diagnosis and Classification of Systemic Lupus Erythematosus 282
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients 281
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFa therapy 275
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. 272
Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study. 271
Grade and location of power Doppler are predictive of damage progression in rheumatoid arthritis patients in clinical remission by anti-tumour necrosis factor α 271
Inflammatory molecules produced by meniscus and synovium in early and end-stage osteoarthritis: a coculture study 271
Erosive osteoarthritis, psoriatic arthritis and pseudogout; a casual association? 270
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes 270
Post-traumatic arthritis: Overview on pathogenic mechanisms and role of inflammation 270
Autoinflammation and autoimmunity: Bridging the divide. 269
Blockade of intra-articular TNF in peripheral spondyloarthritis: Its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers. 267
A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides. 263
Overall Disability Sum Score for Clinical Assessment of Neurological Involvement in Eosinophilic Granulomatosis with Polyangiitis 263
The olfactory function is impaired in patients with idiopathic inflammatory myopathies. 261
Synovial fluid fetuin-A levels in patients affected by osteoarthritis with or without evidence of calcium crystals 260
Evaluation of right ventricular function performed by 3d-echocardiography in scleroderma patients 260
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 258
Anterior chest wall involvement in early stages of spondyloarthritis: Advanced diagnostic tools 257
Update Of Disease Activity Assessment In Rheumatoid Arthritis: Comparison Between Clinical, Ultrasound And Mri Scores And Introduction Of Volumetric Inflammation Measure Concept 256
Lengthening the time intervals between doses of biological agents in psoriatic arthritis patients: A single-center retrospective study 254
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis. 253
Balneotherapy in chronic inflammatory rheumatic diseases—a narrative review 253
Co-stimulatory modulation in rheumatoid arthritis: The role of (CTLA4-Ig) abatacept 252
Basic calcium phosphate and pyrophosphate crystals in early and late osteoarthritis: relationship with clinical indices and inflammation 250
Overlap connective tissue disease syndromes. 247
A recently developed MRI scoring system for hand osteoarthritis: its application in a clinical setting 247
Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra. 246
Effets du traitement par les bains de boue dans le rhumatisme psoriasique chez les patients traités par anti-TNF. Évaluation clinique et par échographie de contraste de l'inflammation synoviale 246
Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy: a randomized controlled trial. 245
Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. 244
Mud-bath treatment of seronegative spondyloarthritis: experience at the Euganean Thermal Area 243
Clinical Guidelines and Definitions of Autoinflammatory Diseases: Contrasts and Comparisons with Autoimmunity-a Comprehensive Review. 242
Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. 242
Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission 242
The clinical features, diagnosis and classification of dermatomyositis. 239
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein i antibodies. A comparison with a homemade ELISA method 236
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 235
Effects of mud-bath therapy in psoriatic arthritis patients treated with TNF inhibitors. Clinical evaluation and assessment of synovial inflammation by contrast-enhanced ultrasound (CEUS). 235
Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy 233
Pregnancy and vasculitis: A systematic review of the literature. 232
Self-reported flares are predictors of radiographic progression in rheumatoid arthritis patients in 28-joint disease activity score remission: a 24-month observational study 232
PRESENCE, GRADE AND LOCATION OF POWER DOPPLER PREDICT PROGRESSION OF RADIOGRAPHIC DAMAGE IN TNFα BLOCKER INDUCED CLINICAL REMISSION IN RHEUMATOID ARTHRITIS PATIENTS 231
Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block. 231
Periodontal Injection of Lipopolysaccharide Promotes Arthritis Development in Mice 231
Elderly onset of primary Sjögren's syndrome: Clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. 230
Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis 230
High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis 230
Realizzazione di colture primarie di sinoviociti fibroblasto-simili a partire da liquido sinoviale 228
Prognosis of scleroderma renal crisis: a long-term observational study. 228
Multiple Dimensions of Self-Esteem and Their Relationship with Health in Adolescence 228
Biomechanical assessment of balance and posture in subjects with ankylosing spondylitis 227
Evaluation of spinal mobility by pocket goniometer (Inclimed R) in patients with ankylosing: preliminary report. 226
Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis 226
A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay. 225
Serological markers of erosive hand osteoarthritis 225
Effect of pathogenic crystals on the production of pro- and anti-inflammatory cytokines by different leukocyte populations 225
Atypical erythema nodosum in atypical tuberculosis presentation 224
Autoinflammatory granulomatous diseases: from Blau syndrome and Early Onset Sarcoidosis to NOD2-mediated disease and Crohn's disease 224
Dynamic Automated Synovial Imaging (DASI) For Differentiating Between Rheumatoid Arthritis And Other Forms Of Arthritis: Automated Versus Manual Interpretation In Contrast-Enhanced Ultrasound 223
CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis 223
Sjogren's syndrome salivary gland ductal epithelial cells display defective scavenging of CXCL10 223
The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. 222
The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients 222
Validation of the italian version of the educational needs assessment tool in rheumatoid arthritis patients and factors associated with educational needs 222
IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis 221
Erosive osteoarthritis 220
Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome. 220
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors 220
The body against self: autoinflammation and autoimmunity. 220
Effect of etanercept on iNOS, IL-6, and COX-2 expression in human chondrocytes in vitro. 219
A combination therapy to treat second-degree anti-ro/la-related congenital heart block. A strategy to avoid stable third-degree heart block? 219
Calprotectin in rheumatic diseases 219
Analisi dell'equilibrio e della postura in soggetti affetti da spondilite anchilosante in trattamento con farmaco biologico 218
Anakinra treatment in drug-resistant Behcet's disease: a case series. 218
Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: The Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study 218
Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up. 218
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients 217
The controversial relationship between osteoarthritis and osteoporosis: an update on hand subtypes 217
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 217
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. 217
YKL-40 as a marker of joint involvement in inflammatory bowel disease 215
Totale 25.273
Categoria #
all - tutte 226.678
article - articoli 218.548
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.972
Totale 448.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021581 0 0 0 0 0 0 0 0 0 0 0 581
2021/20225.954 157 785 561 515 261 333 297 616 273 147 557 1.452
2022/20235.069 1.056 614 104 593 758 696 14 358 576 32 196 72
2023/20242.150 94 251 213 174 121 207 136 136 115 167 243 293
2024/20259.442 36 715 464 401 1.335 258 410 827 738 341 1.547 2.370
2025/202637.577 1.471 3.254 4.870 5.724 3.590 1.667 5.487 3.477 4.021 2.411 1.494 111
Totale 82.139